We thank champions Congressman Neal Dunn, M.D. (FL-02) and Congresswoman Elissa Slotkin (MI-08) for the recent introduction of the Veteran’s Prostate Cancer Treatment and Research Act (H.R. 4880). Since 2016, PCF has been raising awareness and administering $50 million in funding to tackle prostate cancer as the number one cancer diagnosed in the Veterans Health Administration with over 489,000 veterans undergoing treatment. This historic bill will direct the Secretary of Veterans Affairs to establish a clinical pathway for prostate cancer, a standardized system of care for the treatment of what is the most commonly diagnosed cancer in the veterans’ health system. This is an important step toward our mutual goal to end death and suffering from prostate cancer among Veterans.
“The Prostate Cancer Foundation proudly supports this important legislation which will deliver on the promise of precision oncology for Veterans with prostate cancer,” said Jonathan W. Simons, MD, on behalf of the PCF Board of Directors. “PCF is deeply committed to advancing research and care through our long-standing partnership with the Department of Veterans Affairs. It is our duty to ensure that no Veteran is left behind when medical breakthroughs come to the clinic.”